Bioprinting News and Research

RSS

Bioprinting involves the use of 3D printing technology to build tissues and organs. Bioprinting precisely places cells, proteins, DNA, drug particles, growth factors and biologically active particles spatially to guide tissue generation and formation. It has been used extensively in the field of regenerative medicine.

New artificial lung mimics breathing and alveolar movement

Almost everyone has blown a soap bubble through a straw at least once. Inspired by this thin soap bubble film, an "artificial lung that breathes" like a real lung has been developed.

25 Aug 2026

Penn State team lays groundwork to 3D print spheroids for regenerating bone tissue

An interdisciplinary team of engineers and chemists at Penn State has laid the groundwork to 3D print spheroids - tiny clusters of living cells - capable of regenerating bone tissue in response to severe trauma or infections.

18 Aug 2026

NIH funds UVA research to develop advanced laboratory tissue models

A University of Virginia researcher has received a five-year, $2.1 million National Institutes of Health grant to develop advanced laboratory tissue models that could improve drug testing, deepen scientists' understanding of disease and reduce the need for animal testing.

30 Jul 2026

New AI platform tracks cancer treatment responses in tumor organoids

Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have developed a new platform that combines 3D bioprinting, advanced imaging and artificial intelligence to better monitor how cancer responds to treatment.

22 Jun 2026

AI-engineered p53 superproteins may reshape future cancer therapies

The Oncodarwinian Hypothesis (OdH) proposes a paradigm shift: cancer is not merely a disease but a potential macro‑immunoadaptive response – a self‑replicating algorithm that can be reprogrammed via AI‑based 3D printed p53 superproteins.

22 May 2026

Advanced 3D heart models could transform cardiovascular drug discovery

Cardiovascular disease remains a leading global health burden, yet many preclinical systems still struggle to predict how candidate drugs will perform in the human heart.

10 May 2026

Space research accelerates heart disease studies and tissue engineering

By studying and engineering heart tissue in the unique low-gravity environment of space, the laboratory of Arun Sharma, PhD, is uncovering new ways to protect and repair the failing heart.

25 Apr 2026

Zebrafish reveal how new kidney units connect and function

MDI Bio Lab scientists discover how the fish solves a basic challenge in regenerative biology-insights in their newest publication in the journal Development could one day guide human repair.

17 Mar 2026

Electrohydrodynamic bioprinting creates living muscle tissues with tightly aligned cells inside

Building functional human muscle in the laboratory has long been a goal of regenerative medicine, but one stubborn obstacle remains: real muscle is not just a mass of cells.

2 Mar 2026

New 3D liver reconstructions show how cirrhosis reshapes organ architecture

Never-before-seen 3D reconstructions of human liver tissue have been created at a cellular level. The details obtained by a team of UW Medicine and University of Washington engineers and physicians capture the spatial microstructure of multiple lobes of this multitasking organ.

23 Feb 2026

Bioprinting personalized kidney tissues to combat transplant shortages

Rice University bioengineer Antonios Mikos is part of a team of researchers led by the Wake Forest Institute for Regenerative Medicine awarded up to $24.8 million over five years to help address the nation's growing organ donor shortage by bioprinting on-demand kidney tissues.

7 Feb 2026

Ride Cincinnati grant funds research on immune activating wafer for glioblastoma treatment

A multidisciplinary team of University of Cincinnati Cancer Center researchers has received a $40,000 Ride Cincinnati grant to study a delayed release preparation, or wafer, of an immunostimulatory molecule to stimulate the central nervous system (CNS) immune system after surgery to remove glioblastoma, a form of primary brain cancer.

3 Feb 2026